Appili Therapeutics Inc

Company Profile

• Business description

  Appili Therapeutics Inc is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, it develops a pipeline of novel therapies to prevent deaths and improve lives. The company is advancing a diverse range of anti-infectives, including an FDA approved ready-made suspension of metronidazole for the treatment of antimicrobial resistant infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical antiparasitic for the treatment of a disfiguring disease. Its pipeline includes ATI-1701, ATI-1801, ATI-1501.

• Contact

  No. 21-1344 Summer Street
  HalifaxNSB3H 0A8
  CAN

  T: +1 905 442-4655

  https://www.appilitherapeutics.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 March 2027

  Employees

  7